THE MECHANISM OF BLOOD PRESSURE-LOWERING EFFECT OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS IN PATIENTS WITH OBESE TYPE 2 DIABETES MELLITUS

Blood Pressure Lowering ◽

Blood Pressure Lowering Effect ◽

Lowering Effect ◽

Sodium Glucose Cotransporter ◽

Blood Pressure-Lowering Effect of Nebivolol in Hypertensive Patients with Type 2 Diabetes Mellitus

Clinical Drug Investigation ◽

10.2165/00044011-200727120-00006 ◽

2007 ◽

Vol 27 (12) ◽

pp. 841-849 ◽

Cited By ~ 19

Author(s):

Andre C Schmidt ◽

Christine Graf ◽

Klara Brixius ◽

Juergen Scholze

Keyword(s):

Diabetes Mellitus ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Blood Pressure Lowering ◽

Blood Pressure Lowering Effect ◽

Hypertensive Patients ◽

Lowering Effect ◽

Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes

BMC Pharmacology and Toxicology ◽

10.1186/s40360-017-0125-x ◽

2017 ◽

Vol 18 (1) ◽

Cited By ~ 30

Author(s):

Shin Kawasoe ◽

Yukiko Maruguchi ◽

Shoko Kajiya ◽

Hitoshi Uenomachi ◽

Masaaki Miyata ◽

...

Keyword(s):

Blood Pressure ◽

Type 2 Diabetes ◽

Obese Patients ◽

Blood Pressure Lowering ◽

Blood Pressure Lowering Effect ◽

Lowering Effect ◽

Sodium Glucose Cotransporter ◽

HT3 COST-EFFECTIVENESS OF BLOOD PRESSURE LOWERING WITH A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN TYPE 2 DIABETES MELLITUS: A TRIAL-BASED ANALYSIS USING THE ADVANCE STUDY

Value in Health ◽

10.1016/s1098-3015(11)73064-9 ◽

2010 ◽

Vol 13 (7) ◽

pp. A504

Author(s):

PM Clarke ◽

P Glasziou ◽

J Alexander ◽

J Chalmers ◽

A Patel

Keyword(s):

Diabetes Mellitus ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Cost Effectiveness ◽

Fixed Combination ◽

Blood Pressure Lowering ◽

Advance Study ◽

Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT

Journal of the American Heart Association ◽

10.1161/jaha.118.009326 ◽

2018 ◽

Vol 7 (18) ◽

Cited By ~ 19

Author(s):

Srinivasan Beddhu ◽

Glenn M. Chertow ◽

Tom Greene ◽

Paul K. Whelton ◽

Walter T. Ambrosius ◽

...

Keyword(s):

Diabetes Mellitus ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Glycemic Control ◽

Systolic Blood Pressure ◽

Cardiovascular Events ◽

Blood Pressure Lowering ◽

Rationale and design of the AdRem study: Evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus

Contemporary Clinical Trials ◽

10.1016/j.cct.2006.08.011 ◽

2007 ◽

Vol 28 (1) ◽

pp. 6-17 ◽

Cited By ~ 15

Author(s):

Ronald P. Stolk ◽

Johannes R. Vingerling ◽

J. Kennedy Cruickshank ◽

Alun D. Hughes ◽

Alice Stanton ◽

...

Keyword(s):

Diabetes Mellitus ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Glucose Control ◽

Blood Pressure Lowering ◽

Intensive Glucose Control ◽

Retinal Disorders ◽

Predicting the Effects of Blood Pressure–Lowering Treatment on Major Cardiovascular Events for Individual Patients With Type 2 Diabetes Mellitus

Hypertension ◽

10.1161/hypertensionaha.114.04421 ◽

2015 ◽

Vol 65 (1) ◽

pp. 115-121 ◽

Cited By ~ 20

Author(s):

Joep van der Leeuw ◽

Frank L.J. Visseren ◽

Mark Woodward ◽

Sophia Zoungas ◽

Andre Pascal Kengne ◽

...

Keyword(s):

Diabetes Mellitus ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Cardiovascular Events ◽

Blood Pressure Lowering ◽

Major Cardiovascular Events ◽

Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus

Hypertension ◽

10.1161/hypertensionaha.118.12414 ◽

2019 ◽

Vol 73 (6) ◽

pp. 1291-1299 ◽

Cited By ~ 7

Author(s):

Faisal Rahman ◽

John W. McEvoy ◽

Toshiaki Ohkuma ◽

Michel Marre ◽

Pavel Hamet ◽

...

Keyword(s):

Diabetes Mellitus ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Clinical Outcomes ◽

Blood Pressure Lowering ◽

Baseline Blood Pressure ◽

The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) in clinical practice in patients with vascular diseases or type 2 diabetes mellitus

European Journal of Preventive Cardiology ◽

10.1177/2047487312449587 ◽

2012 ◽

Vol 20 (5) ◽

pp. 771-778 ◽

Cited By ~ 12

Author(s):

Melvin Lafeber ◽

Diederick E Grobbee ◽

Wilko Spiering ◽

Yolanda van der Graaf ◽

Michiel L Bots ◽

...

Keyword(s):

Diabetes Mellitus ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Clinical Practice ◽

Vascular Diseases ◽

Blood Pressure Lowering ◽

Combined Use ◽

Seated Cuff Blood Pressure-Lowering Efficacy of an Olmesartan Medoxomil-Based Treatment Regimen in Patients with Type 2 Diabetes Mellitus

Drugs in R&D ◽

10.2165/11592830-000000000-00000 ◽

2011 ◽

Vol 11 (3) ◽

pp. 251-257

Author(s):

Dean J. Kereiakes ◽

Joel M. Neutel

Keyword(s):

Diabetes Mellitus ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Treatment Regimen ◽

Olmesartan Medoxomil ◽

Blood Pressure Lowering ◽

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial

Diabetologia ◽

10.1007/s00125-009-1457-x ◽

2009 ◽

Vol 52 (10) ◽

pp. 2027-2036 ◽

Cited By ~ 101

Author(s):

J. W. J. Beulens ◽

◽

A. Patel ◽

J. R. Vingerling ◽

J. K. Cruickshank ◽

...

Keyword(s):

Diabetes Mellitus ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Controlled Trial ◽

Blood Pressure Lowering ◽

Intensive Glucose Control ◽

Pressure Lowering ◽

Randomised Controlled